Show
Sort by
-
- Journal Article
- A1
- open access
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis : a prospective cohort study in Belgium (2016–2020)
-
- Journal Article
- A1
- open access
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders : a retrospective cohort study
-
- Journal Article
- A1
- open access
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement
-
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis : two-year results of CareRA
-
- Journal Article
- A1
- open access
Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis
-
- Journal Article
- A1
- open access
Illness identity in adults with a chronic illness
-
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
-
- Journal Article
- A1
- open access
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration : the Be-Raise study
-
- Journal Article
- A2
- open access
Costs of drugs for treatment of rheumatic diseases
-
Ten-year followup of infliximab therapy in rheumatoid arthritis patients with severe, longstanding refractory disease: a cohort study
-
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines
-
- Journal Article
- A1
- open access
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial
-
Three-year follow-up of rituximab in rheumatoid arthritis: results from the Belgian MIRA (MabThera in Rheumatoid Arthritis) registry
-
The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile
-
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study
-
Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations
-
A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate
-
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms
-
Identification of novel genes associated with systemic sclerosis through genome wide association study follow-up
-
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort